default author photo

Jacob B. Axelrad

University of Texas MD Anderson Cancer Center - Department of Genomic Medicine

1515 Holocombe Blvd

Houston, TX 77030

United States

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Number of pages: 72 Posted: 18 Mar 2020
University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Surgical Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, Jackson Laboratory for Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology and University of Texas MD Anderson Cancer Center - Department of Genomic Medicine
Downloads 41 (1,170,409)
Citation 1

Abstract:

Loading...

Melanoma, KMT2D, Enhancer, Glycolysis, Chromatin, Epigenetics